WallStreetZenWallStreetZen

NASDAQ: URGN
Urogen Pharma Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Urogen Pharma revenue was $90.40M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $24.6M, down 2.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, URGN annual revenue was $90.4M, with 9.3% growth year-over-year.

URGN past revenue growth

How has URGN's revenue growth performed historically?

Company
9.29%
Industry
497.69%
Market
20.68%
URGN's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
URGN's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
URGN's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

URGN revenue history

Current Revenue
$90.4M
Current Earnings
-$126.9M
Current Profit Margin
-140.4%

Be the first to know when URGN announces revenue.

URGN Revenue History By Year

URGN Yearly RevenueURGN RevenueURGN ChangeURGN Revenue Growth
2024-12-31$90.40M$7.69M+9.29%
2023-12-31$82.71M$18.36M+28.52%
2022-12-31$64.36M$16.32M+33.96%
2021-12-31$48.04M$36.24M+307.17%
2020-12-31$11.80M$11.78M+65,450.00%
2019-12-31$18.00k-$1.11M-98.40%
2018-12-31$1.13M-$7.03M-86.17%
2017-12-31$8.16M-$9.37M-53.46%
2016-12-31$17.53MN/AN/A
2015-12-31$0.00N/AN/A

1 of 1

Urogen Pharma Revenue FAQ

What was URGN's revenue last quarter?

On Invalid Date, Urogen Pharma (NASDAQ: URGN) reported Q4 2024 revenue of $24.57 million up 4.4% year over year. In the same quarter last year, Urogen Pharma's revenue was $23.53 million.

What was Urogen Pharma's revenue in 2024?

Urogen Pharma's annual revenue for the twelve months ending Dec 31, 2024 was $90.40 million, a 9.29% increase year over year.

How much does Urogen Pharma make in a day?

Based on Urogen Pharma annual revenue for the past five years, URGN makes an average of $162,909.04 per day.

What was Urogen Pharma's annual revenue growth in the past year?

As of Q2 2025, Urogen Pharma's revenue has grown 9.29% year over year. This is 488.4 percentage points lower than the US Biotechnology industry revenue growth rate of 497.69%. Urogen Pharma's revenue in the past year totaled $90.40 million.

How much does Urogen Pharma make in a year?

Urogen Pharma's revenue by year for the past five years is:
  • Urogen Pharma's revenue for the twelve months ending Dec 31, 2024 was $90.40 million, a 9.29% increase year over year.
  • Urogen Pharma's annual revenue for Dec 31, 2023 was $82.71 million, a 28.52% increase from 2022.
  • Urogen Pharma's annual revenue for 2022 was $64.36 million, a 33.96% increase from 2021.
  • Urogen Pharma's annual revenue for 2021 was $48.04 million, a 307.17% increase from 2020.
  • Urogen Pharma's annual revenue for 2020 was $11.80 million, a 65,450% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.